Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03999749
Brief Title: A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma

First Submitted : June 25, 2019
First Submitted that Met QC Criteria : June 25, 2019
First Posted : June 27, 2019

Last Update Submitted that Met QC Criteria : August 18, 2020
Last Update Posted : August 19, 2020